AstroNova Inc Q1 2026 Earnings A Loss Per Share Amid Quiet Revenue Disclosure KRO Q1 2026 Earnings Surprise Profit Beat Drives 223 Stock Gain NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase Chimera Investment Corporation CIM Q1 2026 Earnings EPS Beats Estimate Stock Edges Lower BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Amid Steep Stock Decline